Skip to main content

Advertisement

Table 2 Predictors of long-term pancreatic complications for patients with documented pancreatic duct diameter after operation

From: Pancreatic duct obstruction after pancreaticojejunostomy: implications for early prediction and prevention of long-term pancreatic complications

Variable Long-term complication rate Univariate p value Multivariate p value OR (95% CI)
Preoperative pancreatic duct diameter  3mm, n (%)     
 No 10/42 (23.8%) 0.777   
 Yes 6/32 (18.8%)    
Postoperative pancreatic duct diameter  3mm, n (%)     
 No 5/53 (9.4%) < 0.001 0.002 19.0 (3.022-118.984)
 Yes 13/25 (52.0%)    
Postoperative pancreatic parenchymal atrophy, n (%)    0.001 21.2 (3.324-135.697)
 No 5/56 (8.9%) < 0.001   
 Yes 13/22 (59.1%)    
Pathology, n (%)     
 Benign 12/35 (34.3%) 0.057 0.253 0.4 (0.067-2.038)
 Malignant 6/43 (14.0%)    
Type of operation, n (%)     
 Pancreaticoduodenectomy 16/73 (21.9%) 0.326   
 Segment resection of pancreas 2/5 (40.0%)    
Pancreatic fistula, n (%)     
 No 15/61 (24.6%) 0.748   
 Yes 3/17 (17.6%)    
Adjuvant therapy, n (%)     
 No 13/59 (22.0%) 0.002 0.087 9.3(0.725-118.506)
 Chemotherapy 0/12 (0.0%)    
 long-acting octreotide 5/7 (71.4%)    
I125 radioactive seeds implantation, n (%)     
 No 18/74 (24.3%) 1.000   
 Yes 0/3 (0.0%)    
Pancreatic duct stent retained > 2 years, n (%)     
 No 18/68 (26.5%) 0.068   
 Yes 0/10 (0.0%)